Piramal Pharma eyes complex drug demand for earnings boost: Nandini Piramal
Published on: April 29, 2026, 5:14 p.m. | Source: Moneycontrol
"Biotech funding in the second half of the year was about 80% higher than in the second half of last year, and that is now translating into higher requests for proposals and order inflows," Nandini Piramal, chairperson of Piramal Pharma, said
